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The 2016 WHO guidelines on antenatal care1 were 
published earlier this month and are widely welcomed 
because they are not only academically robust, but 
also relevant to end-users and patients. The guidelines 
cover antenatal care for normal pregnancies and have 
adopted a woman-centred, holistic approach to care. 
They cover nutritional interventions, maternal and 
fetal assessment, preventive measures, interventions 
for common physiological pregnancy symptoms, 
and health systems interventions to improve the use 
and quality of antenatal care. The guidelines address 
antenatal evidence-based practices that improve 
outcomes and detail how these practices should be 
delivered. In addition to standard antenatal medical 
advice, the 49 recommendations include guidance 
on psychological support, nutrition, and domestic 
violence screening. Each recommendation is backed 
up with an evidence review, generally based upon 
systematic reviews conducted by the Cochrane 
Collaboration. But even with the most rigorous 
analyses of the evidence, there are conflicting opinions 
as to how to deal with some of the results, and what 
to recommend when there is very limited evidence 
to support or reject common practice. The WHO 
antenatal care Guideline Development Group (GDG) is 
to be congratulated for putting into practice the old 
adage that “no evidence of benefit is not the same as 
evidence of no benefit”. So in symphysis-fundal height 
measurement, for example, where there is limited 
evidence for its benefit, they do not discard it but 
recommend that clinicians continue whatever is their 
current practice.
Some of the recommendations might come as 
a surprise to clinicians, for example, the use of 
acupuncture as an option for early pregnancy nausea 
or low back pain during pregnancy, or magnesium or 
calcium supplements for the treatment of leg cramps. 
Other recommendations represent a shift from 
the traditional model of antenatal care, such as the 
recommendations for caseload/team midwifery or 
group antenatal care in settings with well developed 
midwifery systems. Others represent a matter of 
judgment, including the recommendation for one 
routine ultrasound scan, performed before 24 weeks 
of gestation to estimate gestational age, improve 
detection of fetal anomalies and multiple pregnancies, 
reduce induction of labour for post-term pregnancy, 
and improve a woman’s pregnancy experience. The 
choice of timing of this single scan has little evidence 
behind it but a late second trimester scan is too late for 
accurate dating, and too early for accurate placental 
site localisation or for detection of fetal growth 
restriction. The GDG has partly justified this timing so 
as to detect congenital abnormalities, even though 
there are few interventions available for this to change 
fetal outcome other than pregnancy termination. 
As such, the detection of fetal abnormalities is rarely 
a priority in resource constrained settings and, by 
24 weeks, termination of pregnancy is illegal in 
many settings. It might have made more sense to 
recommend an earlier dating scan, ideally performed 
before 16 weeks of gestation, which would also 
detect multiple pregnancies and the most serious of 
abnormalities like anencephaly. A further optional 
scan could then be offered at 20 weeks of gestation 
according to culture, a woman’s wishes, and availability 
of resources to detect and treat fetal abnormalities.
Perhaps the most striking of the recommendations 
in the new guidelines is that for antenatal care 
contacts. The new guidelines recommend a minimum 
of eight routine antenatal visits (now renamed 
contacts) for both primigravid and parous women with 
the initial contact in the first trimester, two contacts 
in the second trimester, and five contacts scheduled 
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in the third trimester. WHO studies undertaken in the 
1990s had suggested that a four-contact schedule was 
adequate,2 and WHO had implemented this approach.3 
However, updated systematic reviews now suggest 
that this is less acceptable to women and results 
in a 15% excess of perinatal deaths compared with 
eight or more visits, with no difference in maternal 
outcomes.4 The GDG estimates that this equates to 
about four extra perinatal deaths per 1000 births in a 
typical low-resource setting with a perinatal mortality 
rate of 25 per 1000  births. Although the aspiration 
for additional care is to be welcomed, some will 
question the huge investment required to achieve this 
upscaling of antenatal visits for all women. Indeed, 
even the latest UK National Institute for Health and 
Care Excellence antenatal care guidelines recommend 
only seven antenatal contacts for healthy multiparous 
women, although ten for nulliparous women.5 The 
GDG correctly points out that implementing these 
guidelines globally will result in an increased financial 
burden for both the health system and the healthy 
women who are advised to have fortnightly contacts 
in the last 6 weeks of pregnancy, often travelling 
long distances to reach the health facility. Over half 
of all perinatal deaths result from deficiencies in 
intrapartum care,6 and care providers in settings with 
severely constrained budgets will need to consider 
carefully the relative benefits of investing in these 
additional antenatal care contacts for low risk women 
or improving the quality of intrapartum care. 
And that takes us to the problem with most 
guidelines, especially for low-resource settings. 
Although they provide aspirations for optimal clinical 
care, they rarely address the relative cost-effectiveness 
of the various aspects of care, especially against other 
health interventions outside of that guideline. There 
is often intense competition for health budgets, and 
governments and health-care providers are frequently 
left without robust evidence-based guidance on the 
critical issue of cost-effectiveness. This can often 
lead to the choice of the headline action—like eight 
antenatal care contacts—rather than the less tangible 
issue of quality improvement. Future guidelines would 
benefit from a list of the most cost-effective actions for 
implementation. For in places with highly constrained 
budgets, this can make the difference between life and 
death for many women and their babies.
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